Search research articles
Contact Us
Filters
Showing results (141-150 of 167) with videos related to
Page
of 17
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
February 8, 2017
Posterior Reversible Encephalopathy Syndrome Associated With Dose-adjusted EPOCH (Etoposide, Prednisone, Vincristine, Cyclophosphamide, Doxorubicin) Chemotherapy
Abby E Floeter, Amila Patel, Melinda Tran, et al.
Cancer
|
November 21, 2015
Phase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomas
David Schiff, Annick Desjardins, Timothy Cloughesy, et al.
Cancer
|
August 1, 2009
Gender disparity in the rate of partner abandonment in patients with serious medical illness
Michael J Glantz, Marc C Chamberlain, Qin Liu, et al.
Journal of Neuro-Oncology
|
April 18, 2014
A phase 2 trial of verubulin for recurrent glioblastoma: a prospective study by the Brain Tumor Investigational Consortium (BTIC)
Marc C Chamberlain, Sean Grimm, Surasak Phuphanich, et al.
Journal of Neurosurgery
|
March 21, 2007
Irinotecan: a potential new chemotherapeutic agent for atypical or malignant meningiomas
Vinay Gupta, Yuzhuang S Su, Christian G Samuelson, et al.
Anticancer Research
|
May 7, 2013
Prolonged survival of patients with breast cancer-related leptomeningeal metastases
Emilie Le Rhun, Sophie Taillibert, Fahed Zairi, et al.
Neuro-Oncology
|
July 10, 2010
A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma
Myrna R Rosenfeld, Marc C Chamberlain, Stuart A Grossman, et al.
Cancer
|
July 29, 2010
A phase 2 trial of single-agent bevacizumab given in an every-3-week schedule for patients with recurrent high-grade gliomas
Jeffrey J Raizer, Sean Grimm, Marc C Chamberlain, et al.
BBA Clinical
|
January 6, 2015
O<sup>6</sup>-methylguanine-DNA methyltransferase activity is associated with response to alkylating agent therapy and with <i>MGMT</i> promoter methylation in glioblastoma and anaplastic glioma
Michael S Bobola, Mohammad Alnoor, John Y-S Chen, et al.
Anti-Cancer Drugs
|
August 22, 2013
Salvage intracerebrospinal fluid thiotepa in breast cancer-related leptomeningeal metastases: a retrospective case series
Emilie Le Rhun, Sophie Taillibert, Patrick Devos, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 167) with videos related to
Sort By:
Page
of 17
Clinical Lymphoma, Myeloma & Leukemia
|
February 8, 2017
Posterior Reversible Encephalopathy Syndrome Associated With Dose-adjusted EPOCH (Etoposide, Prednisone, Vincristine, Cyclophosphamide, Doxorubicin) Chemotherapy
Abby E Floeter, Amila Patel, Melinda Tran, et al.
Cancer
|
November 21, 2015
Phase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomas
David Schiff, Annick Desjardins, Timothy Cloughesy, et al.
Cancer
|
August 1, 2009
Gender disparity in the rate of partner abandonment in patients with serious medical illness
Michael J Glantz, Marc C Chamberlain, Qin Liu, et al.
Journal of Neuro-Oncology
|
April 18, 2014
A phase 2 trial of verubulin for recurrent glioblastoma: a prospective study by the Brain Tumor Investigational Consortium (BTIC)
Marc C Chamberlain, Sean Grimm, Surasak Phuphanich, et al.
Journal of Neurosurgery
|
March 21, 2007
Irinotecan: a potential new chemotherapeutic agent for atypical or malignant meningiomas
Vinay Gupta, Yuzhuang S Su, Christian G Samuelson, et al.
Anticancer Research
|
May 7, 2013
Prolonged survival of patients with breast cancer-related leptomeningeal metastases
Emilie Le Rhun, Sophie Taillibert, Fahed Zairi, et al.
Neuro-Oncology
|
July 10, 2010
A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma
Myrna R Rosenfeld, Marc C Chamberlain, Stuart A Grossman, et al.
Cancer
|
July 29, 2010
A phase 2 trial of single-agent bevacizumab given in an every-3-week schedule for patients with recurrent high-grade gliomas
Jeffrey J Raizer, Sean Grimm, Marc C Chamberlain, et al.
BBA Clinical
|
January 6, 2015
O<sup>6</sup>-methylguanine-DNA methyltransferase activity is associated with response to alkylating agent therapy and with <i>MGMT</i> promoter methylation in glioblastoma and anaplastic glioma
Michael S Bobola, Mohammad Alnoor, John Y-S Chen, et al.
Anti-Cancer Drugs
|
August 22, 2013
Salvage intracerebrospinal fluid thiotepa in breast cancer-related leptomeningeal metastases: a retrospective case series
Emilie Le Rhun, Sophie Taillibert, Patrick Devos, et al.
Page
of 17